Metronomic schedule of paclitaxel is effective in hormone receptor-positive and hormone receptor-negative breast cancer.
Mehta
Rita S
RS
Jackson
Donna
D
Schubbert
Toni
T
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage*; D011987:Receptors, Steroid / Q000032:analysis*
D000972:Antineoplastic Agents, Phytogenic; D011987:Receptors, Steroid; D017239:Paclitaxel